Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 2/20 | 0.52 |
| ▸ | LCK | P06239 | 1/20 | 0.52 |
| ▸ | LYN | P07948 | 1/20 | 0.52 |
| ▸ | KDR | P35968 | 12/20 | 0.50 |
| ▸ | EGFR | P00533 | 12/20 | 0.50 |
| ▸ | PIK3CD | O00329 | 11/20 | 0.50 |
| ▸ | PIK3CA | P42336 | 11/20 | 0.50 |
| ▸ | PIK3CB | P42338 | 11/20 | 0.50 |
| ▸ | PIK3CG | P48736 | 11/20 | 0.50 |
| ▸ | PRKDC | P78527 | 11/20 | 0.50 |
| ▸ | ABL1 | P00519 | 11/20 | 0.50 |
| ▸ | SRC | P12931 | 11/20 | 0.50 |
| ▸ | HCK | P08631 | 10/20 | 0.50 |
| ▸ | MTOR | P42345 | 10/20 | 0.50 |
| ▸ | EPHB4 | P54760 | 10/20 | 0.50 |
| ▸ | PI4KB | Q9UBF8 | 5/20 | 0.48 |
| ▸ | RET | P07949 | 4/20 | 0.48 |
| ▸ | ABL2 | P42684 | 1/20 | 0.47 |
| ▸ | NUDT14 | O95848 | 1/20 | 0.46 |
| ▸ | NUDT5 | Q9UKK9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19335163 | 0.77 | BTK (0.77) | BTKLCKLYNKDREGFR | |
| SCHEMBL3785235 | 0.76 | PIK3CD (0.51) | KDREGFRPIK3CDPIK3CAPIK3CB | |
| SCHEMBL13063879 | 0.76 | SRC (0.61) | BTKLCKLYNKDREGFR | |
| SCHEMBL19335162 | 0.74 | BTK (0.80) | BTKLCKLYNKDREGFR | |
| SCHEMBL3787803 | 0.74 | RET (0.62) | BTKLCKLYNKDREGFR | |
| SCHEMBL2360644 | 0.73 | BTK (0.79) | BTKLCKLYNKDREGFR | |
| SCHEMBL19335172 | 0.73 | BTK (0.79) | BTKLCKLYNKDREGFR | |
| SCHEMBL19335138 | 0.73 | BTK (0.79) | BTKLCKLYNKDREGFR | |
| SCHEMBL22364036 | 0.73 | BTK (0.79) | BTKLCKLYNKDREGFR | |
| SCHEMBL21540336 | 0.73 | PIK3CD (0.56) | BTKLCKLYNKDREGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100331297-A1 | MODULATION OF PROTEIN TRAFFICKING | FOLDRX PHARMACEUTICALS, INC. (US) | 2010-12-30 | — | — | US | disclosed |
| US-20100331297-A1 | MODULATION OF PROTEIN TRAFFICKING | FOLDRX PHARMACEUTICALS, INC. (US) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100331297-A1 | MODULATION OF PROTEIN TRAFFICKING | RAB1A, COPB1, GOLT1B | BTK 3999/4885LCK 1980/4885LYN 2238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.